Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Alternate-day treatment with S-1 in patients with gastric cancer: a retrospective study of strategies for reducing toxicity.

Sakuma K, Hosoya Y, Arai W, Haruta H, Ui T, Kurashina K, Saito S, Hirashima Y, Yokoyama T, Zuiki T, Hyodo M, Nagai H, Yasuda Y, Shirasaka T.

Int J Clin Oncol. 2010 Apr;15(2):166-71. doi: 10.1007/s10147-010-0036-y. Epub 2010 Mar 2.

PMID:
20195683
2.

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo.

Arai W, Hosoya Y, Haruta H, Kurashina K, Saito S, Hirashima Y, Yokoyama T, Zuiki T, Sakuma K, Hyodo M, Yasuda Y, Nagai H, Shirasaka T.

Int J Clin Oncol. 2008 Dec;13(6):515-20. doi: 10.1007/s10147-008-0780-4. Epub 2008 Dec 18.

PMID:
19093179
3.

Gasless laparoscopy-assisted distal gastrectomy is feasible and useful for non-obese patients with early gastric cancer.

Hyodo M, Hosoya Y, Kurashina K, Saitoh S, Hirashima Y, Yokoyama T, Arai W, Yasuda Y, Nagai H, Sekiguchi C.

Hepatogastroenterology. 2007 Sep;54(78):1854-7.

PMID:
18019734
4.

Minimum leakage rate (0.5%) of stapled esophagojejunostomy with sacrifice of a small part of the jejunum after total gastrectomy in 390 consecutive patients.

Hyodo M, Hosoya Y, Hirashima Y, Haruta H, Kurashina K, Saito S, Yokoyama T, Arai W, Zuiki T, Yasuda Y, Nagai H.

Dig Surg. 2007;24(3):169-72. Epub 2007 Apr 27.

5.

Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.

Arai W, Hosoya Y, Hyodo M, Haruta H, Kurashina K, Saito S, Hirashima Y, Yokoyama T, Zuiki T, Sakuma K, Yasuda Y, Nagai H.

Int J Clin Oncol. 2007 Apr;12(2):146-9. Epub 2007 Apr 27.

PMID:
17443283
6.

Aggressive G-CSF-producing gastric cancer complicated by lung and brain abscesses, mimicking metastases.

Yokoyama T, Hyodo M, Hosoya Y, Koinuma K, Kurashina K, Saitoh S, Hirashima Y, Arai W, Zuiki T, Yasuda Y, Nagai H, Kanai N, Saitoh K.

Gastric Cancer. 2005;8(3):198-201.

PMID:
16086124
7.

Tracheoesophageal fistula secondary to chemotherapy for malignant B-cell lymphoma of the thyroid: successful surgical treatment with jejunal interposition and mesenteric patch.

Hosoya Y, Yokoyama T, Arai W, Hyodo M, Nishino H, Sugawara Y, Yasuda Y, Nagai H.

Dis Esophagus. 2004;17(3):266-9.

PMID:
15361103
8.

Alternate-day oral therapy with TS-1 for advanced gastric cancer.

Arai W, Hosoya Y, Hyodo M, Yokoyama T, Hirashima Y, Yasuda Y, Nagai H, Shirasaka T.

Int J Clin Oncol. 2004 Jun;9(3):143-8.

PMID:
15221596
9.

[A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].

Arai W, Hosoya Y, Yokoyama T, Saito S, Hirashima Y, Hyodo M, Yasuda Y, Nagai H, Shirasaka T.

Gan To Kagaku Ryoho. 2004 Feb;31(2):237-40. Japanese.

PMID:
14997759
10.

Gasless laparoscopy-assisted distal gastrectomy for early cancer via mini-laparotomy using an abdominal wall lift.

Hyodo M, Hosoya Y, Yokoyama T, Arai W, Yasuda Y, Nagai H, Sekiguchi C.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2279-81.

PMID:
14696517
11.

[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].

Arai W, Hosoya Y, Hyodo M, Yokoyama T, Saito S, Kurasina K, Aoki T, Yasuda Y, Nagai H, Tamada K.

Gan To Kagaku Ryoho. 2002 Sep;29(9):1651-5. Japanese.

PMID:
12355955

Supplemental Content

Loading ...
Support Center